You are here » Home » B2B Connect » B2B - Pharma
Divi's Laboratories plant

US FDA issues warning letter for Divi's Laboratories' Visakhapatnam unit

Last month, US drug regulator had issued an import alert on the products manufactured from this unit

News

Narayana Hrudayalaya hospital » More

Features

What’s driving mergers and acquisitions in pharma industry? » More

SUBSCRIBE TO NEWSLETTER

Subscribe to the Business Standard b2b Connect Newsletters and stay updated with lastest news, features, events and more in key industries

Select one or more industry newsletters

Chemical
Plastic & Polymers
Pharma
Manufacturing
Hospitality
All of the above

International News

Research lab image via Shutterstock. » More

Interviews

Role of the leadership to drive sustainability is critical: Jayakumar Krishnaswamy » More

Opinion

Sustainable product design is not about public relations: Dr Mosongo Moukwa » More